BMC Biology (Jun 2018)

Glucocorticoid-dependent REDD1 expression reduces muscle metabolism to enable adaptation under energetic stress

  • Florian A. Britto,
  • Fabienne Cortade,
  • Yassine Belloum,
  • Marine Blaquière,
  • Yann S. Gallot,
  • Aurélie Docquier,
  • Allan F. Pagano,
  • Elodie Jublanc,
  • Nadia Bendridi,
  • Christelle Koechlin-Ramonatxo,
  • Béatrice Chabi,
  • Marc Francaux,
  • François Casas,
  • Damien Freyssenet,
  • Jennifer Rieusset,
  • Sophie Giorgetti-Peraldi,
  • Gilles Carnac,
  • Vincent Ollendorff,
  • François B. Favier

DOI
https://doi.org/10.1186/s12915-018-0525-4
Journal volume & issue
Vol. 16, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Background Skeletal muscle atrophy is a common feature of numerous chronic pathologies and is correlated with patient mortality. The REDD1 protein is currently recognized as a negative regulator of muscle mass through inhibition of the Akt/mTORC1 signaling pathway. REDD1 expression is notably induced following glucocorticoid secretion, which is a component of energy stress responses. Results Unexpectedly, we show here that REDD1 instead limits muscle loss during energetic stresses such as hypoxia and fasting by reducing glycogen depletion and AMPK activation. Indeed, we demonstrate that REDD1 is required to decrease O2 and ATP consumption in skeletal muscle via reduction of the extent of mitochondrial-associated endoplasmic reticulum membranes (MAMs), a central hub connecting energy production by mitochondria and anabolic processes. In fact, REDD1 inhibits ATP-demanding processes such as glycogen storage and protein synthesis through disruption of the Akt/Hexokinase II and PRAS40/mTORC1 signaling pathways in MAMs. Our results uncover a new REDD1-dependent mechanism coupling mitochondrial respiration and anabolic processes during hypoxia, fasting, and exercise. Conclusions Therefore, REDD1 is a crucial negative regulator of energy expenditure that is necessary for muscle adaptation during energetic stresses. This present study could shed new light on the role of REDD1 in several pathologies associated with energetic metabolism alteration, such as cancer, diabetes, and Parkinson’s disease.

Keywords